Skip to main content
Top
Published in: Drugs & Aging 4/2008

01-04-2008 | Original Research Article

Use of Antipsychotics in Older Home Care Patients in Finland

Authors: Dr Hanna-Mari Alanen, Harriet Finne-Soveri, Anja Now, Esa Leinonen

Published in: Drugs & Aging | Issue 4/2008

Login to get access

Abstract

Objective

To investigate the use of antipsychotic medications, and factors associated with such use, in elderly patients in home care in Finland.

Method

A retrospective study was designed using cross-sectional data gathered between 1 July and 31 December 2004 in Finland. Data were extracted from the Resident Assessment Instrument (RAI) database, based on Minimum Data Set for Home Care (MDS-HC) assessments. Patients aged ≥65 years from five home care units in different parts of Finland (urban and rural) were included, yielding a total of 1106 patient assessments.

Results

The prevalence of antipsychotic use was 11% among home care patients. Factors independently associated with use of antipsychotics in the logistic regression model were: any psychiatric diagnosis (odds ratio [OR] 6.62, 95% CI 4.19, 10.45), delusions (OR 4.19, 95% CI 2.22, 7.90), parkinsonism (OR 3.08, 95% CI 1.07, 8.87), not at ease interacting with others (OR 1.88, 95% CI 1.06, 3.36) and moderate-to-severe cognitive impairment (OR 1.47, 95% CI 1.06, 2.04). By contrast, patients aged ≥85 years (OR 0.59, 95% CI 0.43, 0.81) were significantly less likely to be taking antipsychotics. Use of atypical antipsychotic medication was associated in the logistic regression model with delusions (OR 4.05, 95% CI 2.01, 8.17), parkinsonism (OR 3.66, 95% CI 1.10, 12.19), any psychiatric diagnosis (OR 3.06, 95% CI 1.66, 5.63), moderate-to-severe cognitive impairment (OR 2.0, 95% CI 1.32, 3.03) and age ≥85 years (OR 0.66, 95% CI 0.44, 0.99). However, use of conventional antipsychotics was associated only with any psychiatric diagnosis (OR 8.88, 95% CI 5.05, 15.61) and age ≥85 years (OR 0.65, 95% CI 0.44, 0.98).

Conclusion

The prevalence of antipsychotic medication use in elderly home care patients was higher than that previously reported among elderly people living in the community in Finland and Sweden (3–9%). Several predictive factors such as psychiatric diagnosis, delusions and cognitive impairment were associated with use of antipsychotics whereas there was a negative association between age ≥85 years and use of antipsychotics.
Literature
1.
go back to reference Alexopoulos GS, Streim J, Carpenter D, et al. Expert consensus panel for using antipsychotic drugs in older patients. J Clin Psychiatry 2004; 65Suppl. 2: 5–99; discussion 100–2; quiz 103–4PubMed Alexopoulos GS, Streim J, Carpenter D, et al. Expert consensus panel for using antipsychotic drugs in older patients. J Clin Psychiatry 2004; 65Suppl. 2: 5–99; discussion 100–2; quiz 103–4PubMed
2.
go back to reference Giron MS, Forsell Y, Bernsten C, et al. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 2001; 16: 900–6PubMedCrossRef Giron MS, Forsell Y, Bernsten C, et al. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 2001; 16: 900–6PubMedCrossRef
3.
go back to reference Linjakumpu T, Hartikainen S, Klaukka T, et al. Psychotropics among the home-dwelling elderly: increasing trends. Int J Geriatr Psychiatry 2002; 17: 874–83PubMedCrossRef Linjakumpu T, Hartikainen S, Klaukka T, et al. Psychotropics among the home-dwelling elderly: increasing trends. Int J Geriatr Psychiatry 2002; 17: 874–83PubMedCrossRef
4.
go back to reference Hartikainen S, Rahkonen T, Kautiainen H, et al. Use of psychotropics among home-dwelling nondemented and demented elderly. Int J Geriatr Psychiatry 2003; 18: 1135–41PubMedCrossRef Hartikainen S, Rahkonen T, Kautiainen H, et al. Use of psychotropics among home-dwelling nondemented and demented elderly. Int J Geriatr Psychiatry 2003; 18: 1135–41PubMedCrossRef
6.
go back to reference Landi F, Onder G, Cesari M, et al. Comorbidity and social factors predicted hospitalization in frail elderly patients. J Clin Epidemiol 2004; 57: 832–6PubMedCrossRef Landi F, Onder G, Cesari M, et al. Comorbidity and social factors predicted hospitalization in frail elderly patients. J Clin Epidemiol 2004; 57: 832–6PubMedCrossRef
7.
go back to reference Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54Suppl. 5: S4–9PubMed Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000; 54Suppl. 5: S4–9PubMed
8.
go back to reference Finkel SI, Costa e Silva J, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996; 8Suppl. 3: 497–500PubMed Finkel SI, Costa e Silva J, Cohen G, et al. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996; 8Suppl. 3: 497–500PubMed
9.
go back to reference Jeste DV, Finkel SI. Psychosis of Alzheimer’s disease and related dementias: diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 2000; 8: 29–34PubMedCrossRef Jeste DV, Finkel SI. Psychosis of Alzheimer’s disease and related dementias: diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 2000; 8: 29–34PubMedCrossRef
10.
go back to reference Ritchie K, Artero S, Beluche I, et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry 2004; 184: 147–52PubMedCrossRef Ritchie K, Artero S, Beluche I, et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br J Psychiatry 2004; 184: 147–52PubMedCrossRef
11.
go back to reference Henderson AS, Korten AE, Levings C, et al. Psychotic symptoms in the elderly: a prospective study in a population sample. Int J Geriatr Psychiatry 1998; 13: 484–92PubMedCrossRef Henderson AS, Korten AE, Levings C, et al. Psychotic symptoms in the elderly: a prospective study in a population sample. Int J Geriatr Psychiatry 1998; 13: 484–92PubMedCrossRef
12.
go back to reference Forseil Y, Henderson AS. Epidemiology of paranoid symptoms in an elderly population. Br J Psychiatry 1998; 172: 429–32CrossRef Forseil Y, Henderson AS. Epidemiology of paranoid symptoms in an elderly population. Br J Psychiatry 1998; 172: 429–32CrossRef
13.
go back to reference Targum SD, Abbott JL. Psychoses in the elderly: a spectrum of disorders. J Clin Psychiatry 1999; 60Suppl. 8: 4–10PubMed Targum SD, Abbott JL. Psychoses in the elderly: a spectrum of disorders. J Clin Psychiatry 1999; 60Suppl. 8: 4–10PubMed
14.
go back to reference Morris JN, Brant E, Steel K, et al. Comprehensive clinical assessment in community setting: applicability of the MDSHC. Am Geriatr Soc 1997; 45: 1017–24 Morris JN, Brant E, Steel K, et al. Comprehensive clinical assessment in community setting: applicability of the MDSHC. Am Geriatr Soc 1997; 45: 1017–24
15.
go back to reference Kwan CW, Chi I, Lam TP, et al. Validation of the Minimum Data Set for Home Care Assessment Instrument for Hong Kong Chinese Elders. Clin Gerontol 2000; 21(14): 35–48CrossRef Kwan CW, Chi I, Lam TP, et al. Validation of the Minimum Data Set for Home Care Assessment Instrument for Hong Kong Chinese Elders. Clin Gerontol 2000; 21(14): 35–48CrossRef
16.
go back to reference Landi F, Tua E, Onder G, et al. Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med Care 2000; 38: 1184–90PubMedCrossRef Landi F, Tua E, Onder G, et al. Minimum data set for home care: a valid instrument to assess frail older people living in the community. Med Care 2000; 38: 1184–90PubMedCrossRef
17.
go back to reference Schatzberg AF, Nemeroff CB. Essentials of clinical psycho-pharmacology. Washington, DC: American Psychiatry Publishing, 2005 Schatzberg AF, Nemeroff CB. Essentials of clinical psycho-pharmacology. Washington, DC: American Psychiatry Publishing, 2005
18.
go back to reference Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci 1999; 54(11): M546–53PubMedCrossRef Morris JN, Fries BE, Morris SA. Scaling ADLs within the MDS. J Gerontol A Biol Sci Med Sci 1999; 54(11): M546–53PubMedCrossRef
19.
go back to reference Morris JN, Fries BE, Mehr DR, et al. MDS Cognitive Performance Scale. J Gerontol 1994; 49: M174–82PubMedCrossRef Morris JN, Fries BE, Mehr DR, et al. MDS Cognitive Performance Scale. J Gerontol 1994; 49: M174–82PubMedCrossRef
20.
go back to reference Snowdon J, Day S, Baker W. Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Int J Geriatr Psychiatry 2005; 20: 1146–52PubMedCrossRef Snowdon J, Day S, Baker W. Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Int J Geriatr Psychiatry 2005; 20: 1146–52PubMedCrossRef
21.
go back to reference Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353: 2335–41PubMedCrossRef Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353: 2335–41PubMedCrossRef
22.
go back to reference Aarsland D, Larsen JP, Cummings JL, et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 1999; 56: 595–601PubMedCrossRef Aarsland D, Larsen JP, Cummings JL, et al. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 1999; 56: 595–601PubMedCrossRef
23.
go back to reference Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain 2000; 123 (Pt 4): 733–45PubMedCrossRef Fenelon G, Mahieux F, Huon R, et al. Hallucinations in Parkinson’s disease: prevalence, phenomenology and risk factors. Brain 2000; 123 (Pt 4): 733–45PubMedCrossRef
24.
go back to reference Depp CA, Jeste DV. Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry 2006; 14: 6–20PubMedCrossRef Depp CA, Jeste DV. Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry 2006; 14: 6–20PubMedCrossRef
25.
go back to reference Hartikainen S, Rahkonen T, Kautiainen H, et al. Kuopio 75+ study: does advanced age predict more common use of psychotropics among the elderly? Int Clin Psychopharmacol 2003; 18: 163–7PubMed Hartikainen S, Rahkonen T, Kautiainen H, et al. Kuopio 75+ study: does advanced age predict more common use of psychotropics among the elderly? Int Clin Psychopharmacol 2003; 18: 163–7PubMed
Metadata
Title
Use of Antipsychotics in Older Home Care Patients in Finland
Authors
Dr Hanna-Mari Alanen
Harriet Finne-Soveri
Anja Now
Esa Leinonen
Publication date
01-04-2008
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 4/2008
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200825040-00006

Other articles of this Issue 4/2008

Drugs & Aging 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.